Document is current
Any future updates will be listed below
-
Authors
Melhorn, Philipp https://orcid.org/0000-0002-8920-0206
Kretschmer-Chott, Elisabeth
Mazal, Peter
Raderer, Markus
Kiesewetter, Barbara https://orcid.org/0000-0002-5490-2371
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 6 March 2025
Accepted: 6 June 2025
First Online: 21 June 2025
Declarations
:
: This study has received approval from the local Ethics Committee of the Medical University of Vienna (EK No: 1035/2024). Informed consent was waived due to the retrospective design.
: The authors have no conflicts of interest related to the present work. BK received honoraria for lectures or advisory board participation from the following for-profit companies (all outside of the submitted work): from AAA, AstraZeneca, BMS, Boehringer Ingelheim, Ipsen, MSD, Novartis, Eli Lilly, Roche, and Janssen Cilag. MR received honoraria for lectures or advisory board participation from the following for-profit companies (all outside of the submitted work): AbbVie, Gilead, Galapagos Pharma, Celgene, BMS, Ipsen, Novartis, Roche, Eisai, and Eli Lilly. All other authors have no disclosures to report.
